Evidence map›Paper›PMID 32694660›Full record

ArticleNature metabolism2020

Glucose-dependent partitioning of arginine to the urea cycle protects β-cells from inflammation.

Accalia Fu, Juan Carlos Alvarez-Perez, Daina Avizonis, Tatsuya Kin, Scott B Ficarro, Dong Wook Choi, Esra Karakose, Mehmet G Badur, Lindsay Evans, Carolina Rosselot and 12 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Cross-Study Meta-Analysis of Blood Transcriptomes in Type 2 Diabetes.International journal of molecular sciences · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. [Therapeutic efficacy of ASS1 combined with LOLA in the treatment of hyperammonemia in mice].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The mitochondrial enzyme pyruvate carboxylase restricts pancreatic β-cell senescence by blocking p53 activation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 2 countries.

Accalia FuDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Juan Carlos Alvarez-PerezDiabetes, Obesity and Metabolism Institute, Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Daina AvizonisRosalind and Morris Goodman Cancer Center Metabolomics Core, Montreal, Canada.
Tatsuya KinClinical Islet Transplant Program, Department of Surgery, University of Alberta, Edmonton, Canada.ORCID http://orcid.org/0000-0002-5179-6067
Scott B FicarroDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Dong Wook ChoiDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Esra KarakoseDiabetes, Obesity and Metabolism Institute, Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mehmet G BadurRheos Medicines, Cambridge, MA, USA.
Lindsay EvansDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Carolina RosselotDiabetes, Obesity and Metabolism Institute, Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Gaelle BridonRosalind and Morris Goodman Cancer Center Metabolomics Core, Montreal, Canada.
Gregory H BirdDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Hyuk-Soo SeoDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0646-2102
Sirano Dhe-PaganonDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jurre J KamphorstRheos Medicines, Cambridge, MA, USA.
Andrew F StewartDiabetes, Obesity and Metabolism Institute, Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
A M James ShapiroClinical Islet Transplant Program, Department of Surgery, University of Alberta, Edmonton, Canada.
Jarrod A MartoDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2086-1134
Loren D WalenskyDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0869-2334
Russell G JonesMetabolic and Nutritional Programming, Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, USA.
Adolfo Garcia-OcanaDiabetes, Obesity and Metabolism Institute, Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nika N DanialDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nika_danial@dfci.harvard.edu.ORCID http://orcid.org/0000-0003-4842-1827
Harvard University · USIcahn School of Medicine at Mount Sinai · USDana-Farber Cancer Institute · USBrigham and Women's Hospital · USStem Cell Network · CAUniversity of Alberta · CAVan Andel Institute · US

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
The Human Islet Distribution Coordinating Center (UC4)UC4DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI EVANS-MOLINA, CARMELLA, NILAND, JOYCE CAROL · 2012 to 2017
$25.6M
Integrated Islet Distribution Program (U24) - 2021U24DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Carmella Evans-Molina, Joyce Carol Niland · 2021 to 2026
$17.8M
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human CancerR35CA197583 · NCI · DANA-FARBER CANCER INST · PI Loren David Walensky · 2015 to 2026
$12.5M
The Dual Role of Pro-apoptotic BAD in Insulin Secretion and Beta Cell SurvivalR01DK078081 · NIDDK · DANA-FARBER CANCER INST · PI Nika N Danial · 2008 to 2026
$5.7M
DYRK Inhibitors for Human Beta Cell ExpansionR01DK105015 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DEVITA, ROBERT J, GARCIA-OCANA, ADOLFO · 2016 to 2024
$4.9M
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human CancerR50CA211399 · NCI · DANA-FARBER CANCER INST · PI Gregory Howard Bird · 2016 to 2026
$3.2M
Epigenetic Control of Human Beta Cell ProliferationR01DK116873 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ARGMANN, CARMEN, SCOTT, DONALD K. · 2018 to 2022
$3.2M
(PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell LymphomaR01CA219850 · NCI · DANA-FARBER CANCER INST · PI DANIAL, NIKA N, MARTO, JARROD A. · 2018 to 2022
$2.8M
EZH2 in cancer biology and novel inhibitorsR01CA222218 · NCI · DANA-FARBER CANCER INST · PI QI, JUN · 2018 to 2022
$2.6M
Dextran Sulfate, Beta Cell Preservation and Immune Regulation in Type 1 DiabetesR01DK113079 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-OCANA, ADOLFO, HOMANN, DIRK · 2017 to 2020
$1.7M
NCI NIH HHS R01 CA219850NCI NIH HHS R01 CA222218NCI NIH HHS R35 CA197583NCI NIH HHS R50 CA211399NIDDK NIH HHS P30 DK020541NIDDK NIH HHS R01 DK078081NIDDK NIH HHS R01 DK105015NIDDK NIH HHS R01 DK113079NIDDK NIH HHS R01 DK116873NIDDK NIH HHS U24 DK098085NIDDK NIH HHS UC4 DK098085
6 · The paper itself

Abstract

Chronic inflammation is linked to diverse disease processes, but the intrinsic mechanisms that determine cellular sensitivity to inflammation are incompletely understood. Here, we show the contribution of glucose metabolism to inflammation-induced changes in the survival of pancreatic islet β-cells. Using metabolomic, biochemical and functional analyses, we investigate the protective versus non-protective effects of glucose in the presence of pro-inflammatory cytokines. When protective, glucose metabolism augments anaplerotic input into the TCA cycle via pyruvate carboxylase (PC) activity, leading to increased aspartate levels. This metabolic mechanism supports the argininosuccinate shunt, which fuels ureagenesis from arginine and conversely diminishes arginine utilization for production of nitric oxide (NO), a chief mediator of inflammatory cytotoxicity. Activation of the PC-urea cycle axis is sufficient to suppress NO synthesis and shield cells from death in the context of inflammation and other stress paradigms. Overall, these studies uncover a previously unappreciated link between glucose metabolism and arginine-utilizing pathways via PC-directed ureagenesis as a protective mechanism.

Indexed as

AdolescentAdultAgedArginineAspartic AcidCell SurvivalCitric Acid CycleFemaleGlucoseHumansInflammationInsulin-Secreting CellsMaleMetabolomicsMiddle AgedNitric OxideArginineAspartic AcidGlucoseNitric OxidePyruvate CarboxylaseUrea

Identifiers

PMID32694660
PMCPMC7568475
OpenAlexW3021387831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.